Stereoisomers of fatty acid analogs for diagnostic imaging
AssigneeMolecular Insight Pharmaceuticals, Inc.
InventorDavid Elmaleh
Life of this patent
Estimating the term…
Abstract
The present invention provides novel imaging agents for clinical diagnosis of injuries and diseases, in the form of a radionuclide in spatial proximity to a substantially pure stereoisomer of a fatty acid analog. The invention also provides methods for using the novel imaging agents, and kits containing one or more of the novel imaging agents of the invention.
Claims11
A substantially pure stereoisomer of 15-(p-radiohalophenyl)-3-methylpentadecanoic acid, in which radiohalo is selected from the group consisting of radioiodo and radiofluoro.
A method of radio imaging cardiovascular tissue of a subject comprising administering intravenously to a subject an effective amount of a substantially pure stereoisomer of a radionuclide labeled β-methyl fatty acid analog, which is 15-(p-radiohalophenyl)-3-methylpentadecanoic acid.
Dependencies are inferred from the claim text.